We thank Ben Mol for his commendation of the TRUFFLE study.1 We designed this study to reflect management of fetal growth restriction in contemporary clinical practice of fetal medicine from the point of its diagnosis. Crucially, management encapsulates two components: monitoring and delivery. Thus, randomisation was done to one of three groups: cardiotocograph short-term variation, early ductus venosus changes, or late ductus venosus changes when a woman met the inclusion criteria and delivery was on average just over a week after this study entry.